Changes in HIV prevalence and risk among new injecting drug users in a Russian City of high HIV prevalence

Journal of Acquired Immune Deficiency Syndromes

Volumn 47, Issue 5, 2008, Pages 623-631

  Platt, Lucy ^a   Rhodes, Tim ^a   Hickman, Matthew ^b   Mikhailova, Larissa ^c   Lisetsky, Konstantin ^d   Sarang, Anya ^e   Lewis, Kim ^f   Parry, John ^f  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c City Narcological Services and NGO Parents Against Drugs   (Russian Federation)

^d SAMARA NATIONAL RESEARCH UNIVERSITY   (Russian Federation)

^e Russian Harm Reduction Network   (Russian Federation)

^f PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

HIV prevention; Injecting drug use; New injectors; Russia; Sexual risk behavior

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CITY; DISEASE DURATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RUSSIAN FEDERATION; SEXUAL INTERCOURSE;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; MALE; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; RISK-TAKING; RUSSIA; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 41149101561     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318165dbf7     Document Type: Article

References (52)

1. Hamers FF, Downs AM. HIV in Central and Eastern Europe. Lancet. 2003;361:1035-1044.
2. Rhodes T, Ball A, Stimson G, et al. HIV infection associated with drug injecting in the newly independent states, Eastern Europe: the social and economic context of epidemics. Addiction. 1999;94:1323-1336.
3. Rhodes T, Lowndes CM, Judd A, et al. Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia. AIDS. 2002;16:F25-F31.
4. Smolskaya T, Khodakevich LN, Kobyshcha YV, et al. An HIV prevalence study by means of sentinel epidemiological surveillance among injection narcotic abusers in Saint Petersburg. Journal of Microbiology, Epidemiology and Immunobiology. 2000;4:31-33.
5. Kozlov A. HIV incidence and factors associated with HIV acquisition among injection drug users in St. Petersburg, Russia. AIDS. 2006;20:901-906.
6. Davies AG, Dominy NJ, Peters A, et al. HIV in injecting drug users in Edinburgh: prevalence and correlates. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8:399-405.
7. Des Jarlais DC, Marmor M, Friedmann P, et al. HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. Am J Public Health. 2000;90:352-359.
8. Choopanya K, Vanichseni S, Des Jarlais DC, et al. Risk factors and HIV seropositivity among injecting drug users in Bangkok. AIDS. 1991;5:1509-1513.
9. UNAIDS/WHO. Initiating Second Generation HIV Surveillance Systems: Practical Guidelines. Geneva, Switzerland; 2002.
10. UNAIDS/WHO. Guidelines for Second Generation HIV Surveillance: The Next Decade. Geneva, Switzerland; 2000.
11. Cassin S, Geoghegan T, Cox G. Young injectors: a comparative analysis of risk behaviour. Ir J Med Sci. 1998;167:234-237.
12. Miller M, Mella I, Moi H, et al. HIV and hepatitis C virus risk in new and longer term injecting drug users in Oslo, Norway. J Acquir Immune Defic Syndr. 2003;33:373-379.
13. Des Jarlais DC, Friedman SR, Perlis T, et al. Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City. J Acquir Immune Defic Syndr. 1999;20:67-72.
14. Grassly N, Lowndes CM, Rhodes T, et al. Modelling emerging HIV epidemics: the role of injecting drug use and sexual transmission in the Russian Federation, China and India. Int J Drug Policy. 2003;13:25-43.
15. Pokrovskiy V, Ladnaya N, Sokolova E. HIV epidemic in Russia and Eastern Europe: are there any predictors for further heterosexual spreading? Presented at: XIV International AIDS Conference; 2002; Barcelona.
16. Lowndes CM, Alary M, Platt L. Commercial sex work and the HIV/STI epidemic in the Russian Federation. Sex Transm Dis. 2003;30:46-48.
17. Benotsch EG, Somlai AM, Pinkerton SD, et al. Drug use and sexual risk behaviours among female Russian IDUs who exchange sex for money or drugs. Int J STD AIDS. 2004;15:343-347.
18. Aral S, St. Lawrence J. The ecology of sex work and drug use in Saratov Oblast, Russian Federation. Sex Transm Dis. 2002;29:798-805.
19. Ryabenko S. Services for sex workers. Presented at: 12th International Conference on the Reduction of Drug Related Harm; Delhi, India; 2001.
20. Platt L, Rhodes T, Judd A, et al. Effects of sex work on the prevalence of syphilis among injection drug users in 3 Russian cities. Am J Public Health. 2007;97:478-485.
21. Karapetyan AF, Sokolovsky YV, Araviyskaya ER, et al. Syphilis among intravenous drug-using population: epidemiological situation in St. Petersburg, Russia. Int J STD AIDS. 2002;13:618-623.
22. Federal AIDS Centre. Distribution of HIV Positive Cases in Russia by Main Reported Risk Factor from 1987-2004. Federal AIDS Centre, Ministry of Health of the Russian Federation, Moscow; 2007.
23. Lowndes CM, Renton A, Alary M, et al. Conditions for widespread heterosexual spread of HIV in the Russian Federation: implications for research, monitoring and prevention. Int J Drug Policy. 2003;14:45-62.
24. Tichonova LI, Borisenko K, Ward H, et al. Epidemics of syphilis in the Russian Federation: trends, origins and priorities for control. Lancet. 1997;350:210-213.
25. Platt L, Rhodes T, Lowndes CM, et al. The impact of gender and sex work on sexual and injecting risk behaviours and their association with HIV positivity amongst injecting drug users in an HIV epidemic in Togliatti City, Russian Federation. Sex Transm Dis. 2005;32:605-612.
26. Rhodes T, Judd A, Mikhailova L, et al. Injecting equipment sharing among injecting drug users in Togliatti City, Russian Federation. J Acquir Immune Defic Syndr. 2004;35:293-300.
27. Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44:174-198.
28. Heckathorn DD, Semaan S, Broadhead RS, et al. Extensions of respondent driven sampling: a new approach to the study of injection drug users aged 18-25. AIDS Behav. 2002;6:55-67.
29. Magnani R, Sabin K, Saidel T, et al. Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS. 2005;19(Suppl 2): S67-S72.
30. Connell JA, Parry JV. Detection of anti-HIV in saliva and urine at the time of seroconversion. Clin Diagn Virol. 1994;1994:299-311.
31. Tamashiro H, Constantine NT. Serological diagnosis of HIV infection using oral fluid samples. Bull World Health Organ. 1994;72:135-143.
32. Gallo D, George JH, Fitechen AS, et al. Evaluation of a system using oral mucosal transudate for HIV-1 antibody and screening and confirmatory testing. JAMA. 1997;277:254-258.
33. Granade TC, Phillips SK, Parekh B, et al. Detection of antibodies to human immunodeficiency virus type 1 in oral fluids: a large-scale evaluation of immunoassay performance. Clin Diagn Lab Immunol. 1998;5:171-175.
34. Platt L, Rhodes T, Judd A, et al. Effects of sex work on the prevalence of syphilis among injection drug users in 3 Russian cities. Am J Public Health. 2007;97:478-485.
35. Rhodes T, Platt L, Judd A, et al. Hepatitis C virus infection, HIV coinfection, and associated risk among injecting drug users in Togliatti, Russia. Int J STD AIDS. 2005;16:749-754.
36. Rhodes T, Platt L, Maximova S, et al. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: multi-city study. Addiction. 2006;101:252-266.
37. Victora CG, Huttly SR, Fuchs SC, et al. The role of conceptual frameworks in epidemiological analysis: a hierarchical approach. Int J Epidemiol. 1997;26:224-227.
38. Platt L, Hickman M, Rhodes T, et al. The prevalence of injecting drug use in a Russian city: implications for harm reduction and coverage. Addiction. 2004;99:1430-1438.
39. Hagan H, Thiede H, Weiss N, et al. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health. 2001;91: 42-46.
40. Koester S, Heimer R, Baron AE, et al. Risk of hepatitis C virus among young adult injection drug users who share injection equipment. Am J Epidemiol. 2003;157:376.
41. Des Jarlais DC, Paone D, Milliken J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet. 1999;353:1657-1661.
42. Rhodes T, Davis M, Judd A. Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty. Addiction. 2004;99:621-633.
43. Spittal P, Bruneau J, Craib KJP, et al. Surviving the sex trade: a comparison of HIV risk behaviours among street-involved women in two Canadian cities who inject drugs. AIDS Care. 2003;15:187-195.
44. Weber AE, Boivin J-F, Blais L, et al. HIV risk profile and prostitution among female street youths. J Urban Health. 2002;79:525-533.
45. Kral AH, Bluthenthal RN, Lorvick J, et al. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357:1397-1401.
46. Wood E, Schachar J, Li K, et al. Sex trade involvement is associated with elevated HIV incidence among injection drug users in Vancouver. Addiction Research and Theory. 2007;15:321-325.
47. Rhodes T, Mikhailova L, Sarang A, et al. Situational factors influencing drug injecting, risk reduction and syringe exchange practices in Togliatti City, Russian Federation. Soc Sci Med. 2003;57:39-54.
48. Power R, Khalfin R, Nozhkina N, et al. A. An evaluation of harm reduction interventions targeting injecting drug users in Sverdlovsk Oblast, Russia. Int J Drug Policy. 2004;15:305-310.
49. Smolskaya T, Ostrovski D, Kotova S, et al. Sentinel epidemiological surveillance: an efficient way to monitor epidemic situations in poorly accessible groups. Russian Journal of HIV/AIDS and Related Issues. 2000;4:166-167.
50. Bobrova N, Rhodes T, Power R, et al. Barriers to accessing drug treatment in Russia: a qualitative study amongst injecting drug users in two cities. Drug Alcohol Depend. 2006;82 (Suppl 1):S57-S63.
51. Sarang A, Rhodes T, Platt L. Access to syringes in three Russian cities: implications for syringe distribution and coverage. Int J Drug Policy. (In press).
52. Power R. Some methodological and practical implications of employing drug users as indigenous field workers. In: Boulton M, ed. Challenge and Innovation: Methodological Advances in Social Research on HIV/AIDS. London, UK: Taylor and Francis; 1994:97-111.